文献速递重症综合管理与镇静镇痛心脑血管急症

从指征到启动有创颅内压监测的时间差异:神经外科医生与重症医学科医生对比能否减少颅内高压剂量?TIMING-ICP多中心观察性前瞻性研究

From indication to initiation of invasive intracranial pressure monitoring time differences between neurosurgeons and intensive care physicians: can intracranial hypertension dose be reduced? TIMING-ICP, a multicenter, observational, prospective study.
PubMed 文献 · Crit Care · 2025-06-13
一句话结论在ICU内放置脑实质内导管时,由重症医学科医生操作比神经外科医生操作启动更早(平均差异76分钟,P=0.0021)。

这项前瞻性、观察性、多中心研究纳入112例患者,评估从宣布有创颅内压监测指征(T1)到开始操作(T2,皮肤切开)的时间间隔,比较神经外科医生与重症医学科医生操作者的差异。重症医学科医生在ICU内放置脑实质内导管39例,神经外科医生放置脑实质内导管及脑室外引流共73例(ICU和手术室)。ICU内脑实质内导管放置的T2-T1平均差异在重症医学科组为69分钟(CI 50.1-94.8),神经外科组为145分钟(CI 103.4-202.9),组间平均差异76分钟,具统计学显著性(P=0.0021)。神经外科组中ICU与手术室之间的时间无统计学显著差异。作者认为,由重症医学科医生在床旁直接操作可能有助于更早诊断颅内高压,但需进一步研究证实并探讨对结局的影响。

要点

  • ICU内脑实质内导管放置的T2-T1平均时间:重症医学科医生69分钟(CI 50.1-94.8) vs 神经外科医生145分钟(CI 103.4-202.9)。
  • 两组平均差异76分钟,具统计学显著性(P=0.0021),重症医学科医生操作启动更早。
  • 神经外科医生操作的病例中,ICU与手术室之间的时间差异无统计学显著性。
  • 研究纳入112例,其中重症医学科医生放置脑实质内导管39例,神经外科医生放置脑实质内导管及脑室外引流共73例。
  • 作者认为,由重症医学科医生在床旁直接操作可能获得颅内高压的及时诊断。

适用人群与场景

  • 需要放置有创颅内压监测(脑实质内导管或脑室外引流)并住ICU或手术室的患者,共纳入112例进行分析。

诊断标准与关键阈值

  • T1为宣布有创颅内压监测指征的时间,T2为开始操作(皮肤切开)的时间,评估T2-T1时间间隔。

处置流程与药物剂量

  • 有创颅内压监测装置包括脑实质内导管和脑室外引流,可在ICU或手术室进行。
  • 由重症医学科医生在ICU内放置脑实质内导管时,从指征到启动操作的平均时间为69分钟(CI 50.1-94.8)。
  • 由神经外科医生放置脑实质内导管或脑室外引流时,从指征到启动操作的平均时间为145分钟(CI 103.4-202.9)。

研究设计与关键结果

  • 研究类型为前瞻性、观察性、多中心研究,最终分析112例。
  • ICU内脑实质内导管放置的T2-T1平均差异:重症医学科组69分钟(CI 50.1-94.8) vs 神经外科组145分钟(CI 103.4-202.9),组间平均差异76分钟,P=0.0021。
  • 神经外科组中,ICU与手术室之间的操作时间差异无统计学显著性。
  • 共39例脑实质内导管由重症医学科医生在ICU放置,73例脑实质内导管和脑室外引流由神经外科医生在ICU和手术室放置。

证据类型、等级与局限

  • 证据类型:前瞻性、观察性、多中心研究。
  • 作者指出需进一步研究证实这些发现并探讨其对结局的影响。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于需要脑实质内导管监测颅内压的患者,由重症医学科医生在ICU床旁操作可能缩短从指征到启动的时间(平均69分钟 vs 145分钟,差异76分钟,P=0.0021)。
  • 作者认为,由重症医学科医生在床旁直接操作可能获得颅内高压的及时诊断。
  • 作者指出需进一步研究证实这些发现并探讨其对结局的影响。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The duration of episodes of intracranial hypertension is related to poor outcome, hence the need for prompt diagnosis. Numerous issues can lead to delays in the implementation of invasive intracranial pressure (ICP) monitoring, thereby increasing the dose of intracranial hypertension to which the patient is exposed. The aim of this prospective, observational, multicenter study was to assess the magnitude of this delay, evaluating the time required for initiation of invasive ICP monitoring, from indication (T1) to initiation of the maneuver (T2) when performed by neurosurgeons compared to intensive care physicians.

METHODS: We evaluated the impact of the operator performing the maneuver (neurosurgeon vs. intensivist) on the T2-T1 time interval, where T1 represents the time at which indication for invasive ICP monitoring is declared, and T2 the time at which the maneuver starts, defined as the skin incision. The effect of the operator performing the maneuver was evaluated through a parametric survival model. Both intraparenchymal catheters (IPCs) and external ventricular drains (EVDs) were considered as invasive ICP monitoring devices. Invasive monitoring could be performed in intensive care unit (ICU) or in operating room (OR).

RESULTS: A total of 112 patients were included into the final analysis; 39 IPCs were placed by intensivists within the ICU, and a total of 73 IPCs and EVDs by neurosurgeons both within the ICU and OR settings. The mean difference in T2-T1 time for IPCs placement in the ICU was 69 min (CI 50.1-94.8) in the intensivist group and 145 min (CI 103.4-202.9) in neurosurgeon group. The mean difference between these groups, 76 min, was found to be statistically significant (p-value = 0.0021). In the group treated by neurosurgeons, no statistically significant differences were found in timing between the ICU and the OR.

CONCLUSIONS: Invasive ICP monitoring performed with IPCs in ICU begins earlier when performed by intensivists rather than neurosurgeons. This finding suggests the possibility to obtain a prompt diagnosis of intracranial hypertension when intensivists intervein directly at patient's bedside. Further studies are needed to confirm these findings and investigate their effect on outcome.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Mariani L, Calza S, Gritti P, et al. From indication to initiation of invasive intracranial pressure monitoring time differences between neurosurgeons and intensive care physicians: can intracranial hypertension dose be reduced? TIMING-ICP, a multicenter, observational, prospective study. Crit Care. 2025. PMID: 40506776. doi:10.1186/s13054-025-05384-w

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。